Rapid Screening for Cognitive Impairment in Parkinson’s Disease: A Pilot Study

Aim. This study sought to establish the discriminant validity of a rapid cognitive screen, that is, the National Institute of Neurological Disease and Stroke-Canadian Stroke Network (NINDS-CSN) 5-minute protocol, and compare its discriminant validity to the Montreal Cognitive Assessment (MoCA) and M...

Full description

Saved in:
Bibliographic Details
Main Authors: YanHong Dong, Way Inn Koay, Leonard Leong Litt Yeo, Christopher Li-Hsian Chen, Jing Xu, Raymond Chee Seong Seet, Erle Chuen Hian Lim
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Parkinson's Disease
Online Access:http://dx.doi.org/10.1155/2015/348063
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561993373974528
author YanHong Dong
Way Inn Koay
Leonard Leong Litt Yeo
Christopher Li-Hsian Chen
Jing Xu
Raymond Chee Seong Seet
Erle Chuen Hian Lim
author_facet YanHong Dong
Way Inn Koay
Leonard Leong Litt Yeo
Christopher Li-Hsian Chen
Jing Xu
Raymond Chee Seong Seet
Erle Chuen Hian Lim
author_sort YanHong Dong
collection DOAJ
description Aim. This study sought to establish the discriminant validity of a rapid cognitive screen, that is, the National Institute of Neurological Disease and Stroke-Canadian Stroke Network (NINDS-CSN) 5-minute protocol, and compare its discriminant validity to the Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) in detecting cognitive impairment (CI) in PD patients. Methods. One hundred and one PD patients were recruited from a movement disorders clinic in Singapore and they received the NINDS-CSN 5-minute protocol, MoCA, and MMSE. No cognitive impairment (NCI) was defined as Clinical Dementia Rating (CDR) = 0 and CI was defined as CDR ≥ 0.5. Results. Area under the receiver operating characteristic curve of NINDS-CSN 5-minute protocol was statistically equivalent to MoCA and larger than MMSE (0.86 versus 0.90, P=0.07; 0.86 versus 0.76, P=0.03). The sensitivity of NINDS-CSN 5-minute protocol (<9) was statistically equivalent to MoCA (<22) (0.77 versus 0.85, P=0.13) and superior to MMSE (<24) (0.77 versus 0.52, P<0.01) in detecting CI, while the specificity of NINDS-CSN 5-minute protocol (<9) was statistically equivalent to MoCA (<22) and MMSE (<24) (0.78 versus 0.88, P=0.34). Conclusion. The NINDS-CSN 5-minute protocol is time expeditious while remaining statistically equivalent to MoCA and superior to MMSE and therefore is suitable for rapid cognitive screening of CI in PD patients.
format Article
id doaj-art-92c8c115c0eb43ff8f10842a193b694f
institution Kabale University
issn 2090-8083
2042-0080
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Parkinson's Disease
spelling doaj-art-92c8c115c0eb43ff8f10842a193b694f2025-02-03T01:23:38ZengWileyParkinson's Disease2090-80832042-00802015-01-01201510.1155/2015/348063348063Rapid Screening for Cognitive Impairment in Parkinson’s Disease: A Pilot StudyYanHong Dong0Way Inn Koay1Leonard Leong Litt Yeo2Christopher Li-Hsian Chen3Jing Xu4Raymond Chee Seong Seet5Erle Chuen Hian Lim6Department of Pharmacology, Yong Loo Lin School of Medicine, National University Health System, BLK MD3 Level 4 #04-01, 16 Medical Drive, 117600, SingaporeDepartment of Pharmacology, Yong Loo Lin School of Medicine, National University Health System, BLK MD3 Level 4 #04-01, 16 Medical Drive, 117600, SingaporeDivision of Neurology, National University Hospital, 5 Lower Kent Ridge Road, 119074, SingaporeDepartment of Pharmacology, Yong Loo Lin School of Medicine, National University Health System, BLK MD3 Level 4 #04-01, 16 Medical Drive, 117600, SingaporeDepartment of Pharmacology, Yong Loo Lin School of Medicine, National University Health System, BLK MD3 Level 4 #04-01, 16 Medical Drive, 117600, SingaporeDepartment of Medicine, Yong Loo Lin School of Medicine, National University Health System, 1E, Level 10, NUHS Tower Block, Kent Ridge Road, 119228, SingaporeDepartment of Medicine, Yong Loo Lin School of Medicine, National University Health System, 1E, Level 10, NUHS Tower Block, Kent Ridge Road, 119228, SingaporeAim. This study sought to establish the discriminant validity of a rapid cognitive screen, that is, the National Institute of Neurological Disease and Stroke-Canadian Stroke Network (NINDS-CSN) 5-minute protocol, and compare its discriminant validity to the Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) in detecting cognitive impairment (CI) in PD patients. Methods. One hundred and one PD patients were recruited from a movement disorders clinic in Singapore and they received the NINDS-CSN 5-minute protocol, MoCA, and MMSE. No cognitive impairment (NCI) was defined as Clinical Dementia Rating (CDR) = 0 and CI was defined as CDR ≥ 0.5. Results. Area under the receiver operating characteristic curve of NINDS-CSN 5-minute protocol was statistically equivalent to MoCA and larger than MMSE (0.86 versus 0.90, P=0.07; 0.86 versus 0.76, P=0.03). The sensitivity of NINDS-CSN 5-minute protocol (<9) was statistically equivalent to MoCA (<22) (0.77 versus 0.85, P=0.13) and superior to MMSE (<24) (0.77 versus 0.52, P<0.01) in detecting CI, while the specificity of NINDS-CSN 5-minute protocol (<9) was statistically equivalent to MoCA (<22) and MMSE (<24) (0.78 versus 0.88, P=0.34). Conclusion. The NINDS-CSN 5-minute protocol is time expeditious while remaining statistically equivalent to MoCA and superior to MMSE and therefore is suitable for rapid cognitive screening of CI in PD patients.http://dx.doi.org/10.1155/2015/348063
spellingShingle YanHong Dong
Way Inn Koay
Leonard Leong Litt Yeo
Christopher Li-Hsian Chen
Jing Xu
Raymond Chee Seong Seet
Erle Chuen Hian Lim
Rapid Screening for Cognitive Impairment in Parkinson’s Disease: A Pilot Study
Parkinson's Disease
title Rapid Screening for Cognitive Impairment in Parkinson’s Disease: A Pilot Study
title_full Rapid Screening for Cognitive Impairment in Parkinson’s Disease: A Pilot Study
title_fullStr Rapid Screening for Cognitive Impairment in Parkinson’s Disease: A Pilot Study
title_full_unstemmed Rapid Screening for Cognitive Impairment in Parkinson’s Disease: A Pilot Study
title_short Rapid Screening for Cognitive Impairment in Parkinson’s Disease: A Pilot Study
title_sort rapid screening for cognitive impairment in parkinson s disease a pilot study
url http://dx.doi.org/10.1155/2015/348063
work_keys_str_mv AT yanhongdong rapidscreeningforcognitiveimpairmentinparkinsonsdiseaseapilotstudy
AT wayinnkoay rapidscreeningforcognitiveimpairmentinparkinsonsdiseaseapilotstudy
AT leonardleonglittyeo rapidscreeningforcognitiveimpairmentinparkinsonsdiseaseapilotstudy
AT christopherlihsianchen rapidscreeningforcognitiveimpairmentinparkinsonsdiseaseapilotstudy
AT jingxu rapidscreeningforcognitiveimpairmentinparkinsonsdiseaseapilotstudy
AT raymondcheeseongseet rapidscreeningforcognitiveimpairmentinparkinsonsdiseaseapilotstudy
AT erlechuenhianlim rapidscreeningforcognitiveimpairmentinparkinsonsdiseaseapilotstudy